Riyaz Shah
/content/dam/genesiscare/headshots/uk-doctor-headshots/riyaz_shah.jpg

Dr Riyaz Shah

Dr Riyaz Shah
Riyaz
Shah
BSc (Hons), MBBS FRCP, PhD

Languages spoken

English

Expert in

Lung cancer, mesothelioma, thymic cancers

Overview

Centres

Maidstone
Maidstone
17 Kings Hill Avenue, Kings Hill, West Malling, Kent, ME19 4UA, England, UK
51.27660, 0.39425
/uk/our-centres/maidstone
Kent
London Cromwell Hospital
London Cromwell Hospital
GenesisCare London Cromwell Hospital, 164-178 Cromwell Road, Kensington, Middlesex, SW5 0TU, England, UK
51.49546, -0.19115
/uk/our-centres/cromwell-hospital
Middlesex

Dr Shah trained at Guy's and St Thomas' Hospitals between 1988 and 1994, obtaining a First Class Honours Intercalated BSc in Experimental Pathology. He obtained Membership of the Royal College of Physicians of London in 1997.

Dr Shah was awarded a Clinical Research Fellowship by The Imperial Cancer Research Fund undertaking a PhD in cancer gene expression.

Dr Shah subsequently trained to become a specialist in Medical Oncology at The Royal Marsden Hospital and was awarded an ASCO Foundation Merit Award in 2005. He was appointed Consultant Medical Oncologist in 2006.

Dr Shah is a specialist thoracic Medical Oncologist specialising in the treatment of all lung tumours (Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Mesothelioma and Thymic malignancies.

He is involved in training future medical oncologists and has an extensive role in clinical research. He has served on the NCRI Lung Group, acted as Chair of the Kent Lung Network and Research Lead at his cancer centre.

Dr Shah is heavily involved in clinical research. He acts as principal investigator on many trials in his centre and has been a major champion in the introduction of immunotherapy and targeted therapies into routine clinical practice.

He has published widely and regularly speaks both nationally and internationally on cancer issues.

He specialises in all forms of modern systemic therapy including chemotherapy, immunotherapy, kinase inhibitors, bispecifics and antibody drug conjugates.

He has a leadership role within the British Thoracic Oncology Group and acts as a clinical advisor with the UK patient groups EGFR+ and ALK+UK,

Career positions

Current position(s)

  • Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust

Past position(s)

  • Medical Oncology SpR at Royal Marsden Hospital

Year qualified

  • 1994

Education

Universities
 
  • University College London
  • Imperial College London
Fellowship
  • Clinical Research Fellowship by The Imperial Cancer Research Fund
  • Fellow of the Royal College of Physicians (FRCP)

Expertise and interests

Areas of interest
  • Specialist in cancers of the chest (e.g. lung cancer, mesothelioma)
  • Specialist in unknown primary malignancies
  • Specialist in acute oncology
  • Specialist in phase II and III clinical trials;
  • Specialist in immunotherapy, targeted therapy
  • Molecular oncology

Professional association

  • Fellow of Royal College of Physicians of London
  • Member ESMO
  • Member IASLC
  • Member BTOG

Accomplishments

Awards

  • ASCO Foundation Merit Award 2005